Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report

• Main Authors: Xuesong Chen (Author), Wangjian Zha (Author), Mei Su (Author), Nan Meng (Author), Shuliang Cao (Author), Beifang Niu (Author), Xu Qi (Author)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Insertions in exon 20 represent the third most common type of EGFR mutation following in-frame deletions in exon 19 and the point mutation L858R in exon 21. They are generally associated with primary resistance to EGFR-TKIs. Although mobocertinib and amivantamab were approved for adult patients with...